Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE ε4
Authors:
- Annette L. FitzpatrickAFAnnette L. Fitzpatrick
- Oscar L. LopezOLOscar L. Lopez
- Lewis H. KullerLKLewis H. Kuller
- Rita PeilaRPRita Peila
- Anne B. NewmanANAnne B. Newman
- Lenore J. LaunerLLLenore J. Launer
Open Access
- 1 January 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 65 (1) , 89-93
Abstract
In addition to the well-documented damage to large and small vessels, there are multiple neuronal and non-neuronal pathways through which diabetes-associated glycemic dysregulation can cause structural damage in the brain. Hyperglycemia can affect neuronal viability via increased oxidative stress, O-linked glycoprotein, and advanced glycation end products.1-3 Altered metabolism of glucose can also lead to less production of acetylcholine, an important neurotransmitter. Hyperglycemia may lead to hyperosmolarity and increased vasopressin, which eventually results in degeneration of hypothalamic neurons.4 There may also be a direct effect of hyperglycemia on the calcium balance in hippocampal neurons, which could lead to degeneration.5Keywords
This publication has 34 references indexed in Scilit:
- Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related PathologiesDiabetes, 2002
- Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort StudyAmerican Journal of Epidemiology, 1997
- Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyThe Lancet, 1997
- Cerebrovascular Disease, the Apolipoprotein e4 Allele, and Cognitive Decline in a Community-Based Study of Elderly MenStroke, 1996
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filamentsNature, 1994
- The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment CentersNeurology, 1992
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984